Hepatic artery infusion for recurrent or chemoresistant hepatic malignancy.

Abstract

351 Background: Previously treated hepatic colorectal metastases (CRC) and advanced hepatocellular cancer (HCC) are tumor challenges frequently unresponsive to systemic chemotherapy (CT). We reviewed survival outcome in chemoresistant/high-risk patients following hepatic artery infusion (HAI) in 21 CRC pts, 10 HCC pts, and 6 miscellaneous metastatic cancers… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Wanebo2011HepaticAI, title={Hepatic artery infusion for recurrent or chemoresistant hepatic malignancy.}, author={Harold J. Wanebo and S Reddy Sanikommu and Vadlamani Padmaja and Charu Taneja and Francis J. Cummings and Giovanni Begossi and James F. Belliveau}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2011}, volume={29 4_suppl}, pages={351} }